CC1C=CC(S(O)(=O)=O)=CC=1.N1C=CC=CC=1.C[O:19][C:20](OC)(OC)[CH3:21].[F:26][C:27]1[CH:32]=[CH:31][C:30]([N:33]2[C:41]3[CH:40]=[C:39]4[CH2:42][CH2:43][C@@H:44]5[C@@H:49]([C@@:38]4([CH3:60])[CH2:37][C:36]=3[CH:35]=[N:34]2)[C@@H:48]([OH:50])[CH2:47][C@:46]2([CH3:59])[C@:51]([C:55](=[O:58])[CH2:56][OH:57])([OH:54])[CH2:52][CH2:53][C@@H:45]52)=[CH:29][CH:28]=1.O.CC1C=CC(S(O)(=O)=O)=CC=1.C([O-])(O)=O.[Na+]>C(Cl)Cl.O.CCOC(C)=O>[C:20]([O:54][C@@:51]1([C:55](=[O:58])[CH2:56][OH:57])[C@:46]2([CH3:59])[C@H:45]([C@H:44]3[C@H:49]([C@@H:48]([OH:50])[CH2:47]2)[C@@:38]2([CH3:60])[CH2:37][C:36]4[CH:35]=[N:34][N:33]([C:30]5[CH:29]=[CH:28][C:27]([F:26])=[CH:32][CH:31]=5)[C:41]=4[CH:40]=[C:39]2[CH2:42][CH2:43]3)[CH2:53][CH2:52]1)(=[O:19])[CH3:21]According to the literature (Chem. Pharm. Bull. 2006, 54(11), 1567-1570) pyridine 4-methylbenzenesulfonate (0.034 g, 0.14 mmol) and 1,1,1-trimethoxyethane (0.136 ml, 1.06 mmol) were added to a solution of 1-[(1R,3aS,3bS,10aR,10bS,11S,12aS)-7-(4-fluorophenyl)-1,11-dihydroxy-10a,12a-dimethyl-1,2,3,3a,3b,4,5,7,10,10a,10b,11,12,12a-tetradecahydrocyclopenta[5,6]naphtho[1,2-f]indazol-1-yl]-2-hydroxyethanone (Steroids 2003 (68) 177-191) (0.34 g, 0.71 mmol) in DCM (15 ml). The mixture was stirred at room temperature for 4 hours, concentrated under reduced pressure, the obtained residue was dissolved in acetone (10 ml) and 4-methyl benzenesulfonic acid hydrate (0.21 g, 1.10 mmol) dissolved in water (10 ml) was added while cooling in an ice-bath. The mixture was stirred for 60 min. at the same temperature followed by the addition of sat. NaHCO3 solution (15 ml) and subsequent extraction with EtOAc (30 ml). The organic layer was washed with brine, dried and purified on a preparative HPLC column (CH3CN/water) and the product containing fractions were freeze-dried to give 60 mg of the title compound.
読み込み中…